Search results
GSK stock gains on raised profit outlook
Investing.com· 4 days agoThe company's growth was driven by a broad-based performance across its product portfolio, with notable increases in Vaccines sales by 16%, Specialty...
COVID aside, vaccines and asthma drugs deliver strong quarter for GSK
WFMZ Eastern Pennsylvania and Western New Jersey· 4 days agoThe company also said General Medicines, particularly Trelegy, performed better than expected. GSK expects first half 2024 year over year sales growth to be higher than second ...
GSK Beats Q1 Earnings & Sales Estimates, Ups 2024 Guidance
Zacks via Yahoo Finance· 4 days agoGSK's revenues benefit from strong growth across the Specialty Medicines and Vaccines segments. The...
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Benzinga via Yahoo Finance· 4 days agoWednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling...
GSK raises profit outlook on strong vaccine, HIV drug sales
Reuters via Yahoo Finance· 4 days ago(Reuters) -GSK raised its full-year profit forecast on Wednesday on strong demand for its common...
Health Care Roundup: Market Talk
The Wall Street Journal· 4 days ago0921 ET – GSK’s CEO Emma Walmsley says in a press call that she sees expansion opportunities for its respiratory syncytial virus vaccine Arexvy across...
Enlyte Drug Trends Report Indicates Significant Drop of Opioid Use in Comp
KFDX Wichita Falls· 5 days agoEfforts by workers' comp regulators and professionals to control opioid prescriptions and distribution are resulting in one of the largest drops in utilization the workers' comp industry has ...
